Cure Your Asthma Naturally, Click Here!

Santarus to Hold Second Quarter 2010 Financial Results Conference Call on August 2 - MarketWatch (press release)

Santarus to Hold Second Quarter 2010 Financial Results Conference Call on August 2
MarketWatch (press release)
Budesonide MMX is being investigated in a Phase III clinical program for the induction of remission of mild or moderate active ulcerative colitis. ...
Earnings Update: Santarus Releases its Quarterly Earnings on August 03, 2010 ... Comtex Smartrend

all 18 news articles »

continue reading

Salix Pharmaceuticals Announces 2Q2010 Financial Results Conference Call and ... - MarketWatch (press release)

Salix Pharmaceuticals Announces 2Q2010 Financial Results Conference Call and ...
MarketWatch (press release)
Crofelemer, budesonide foam and rifaximin for additional indications are under development. For full prescribing information and important safety ...

and more »

continue reading

Santarus Announces Launch of Prescription ZEGERID Authorized Generic and ... - MarketWatch (press release)

Santarus Announces Launch of Prescription ZEGERID Authorized Generic and ...
MarketWatch (press release)
Budesonide MMX is being investigated in a Phase III clinical program for the induction of remission of mild or moderate active ulcerative colitis. ...

and more »

continue reading

Side effects of Symbicort - Helium

Side effects of Symbicort
Helium
Steroid is Budesonide. Bronchodilator is Formeterol. These inhalation preparations have minimal side effects compared to the oral preparations. ...

continue reading

Santarus to Hold Second Quarter 2010 Financial Results Conference Call on August 2 - Business Wire (press release)

Santarus to Hold Second Quarter 2010 Financial Results Conference Call on August 2
Business Wire (press release)
Santarus is also developing two late-stage lower GI product candidates, budesonide MMX ® and rifamycin SV MMX ® , for the US market. Budesonide MMX is being ...

continue reading

Multiple Factors, Primarily Generic Erosion, Will Cause the Asthma Drug Market ... - PR Newswire (press release)

Multiple Factors, Primarily Generic Erosion, Will Cause the Asthma Drug Market ...
PR Newswire (press release)
... sales include GlaxoSmithKline's Advair/Seretide/Adoair (salmeterol/fluticasone propionate) and AstraZeneca/Astellas's Symbicort (formoterol/budesonide). ...

and more »

continue reading

Cigarette Smoke Exposure Alters mSin3a and Mi-2alpha/beta Expression ... - 7thSpace Interactive (press release)

Cigarette Smoke Exposure Alters mSin3a and Mi-2alpha/beta Expression ...
7thSpace Interactive (press release)
Budesonide alone protected mSin3a protein expression with no additional effect seen with abrogation of PI3Kgamma/delta activity, however Mi-2alpha, ...

continue reading

Salix Pharmaceuticals Announces 2Q2010 Financial Results Conference Call and ... - BioMedReports (subscription)

Salix Pharmaceuticals Announces 2Q2010 Financial Results Conference Call and ...
BioMedReports (subscription)
Crofelemer, budesonide foam and rifaximin for additional indications are under development. For full prescribing information and important safety ...

continue reading

Like Lots of Action; Try: SHOR, CTFO, SNTS - Small Cap Network

Like Lots of Action; Try: SHOR, CTFO, SNTS
Small Cap Network
SNTS sells the Omeprazole tablet, which is approved for the treatment of upper gastrointestinal conditions, SNTS is developing Budesonide MMX, ...

continue reading

AstraZeneca Targets Emerging Markets - Pharma and Healthcare Insight (registration)

AstraZeneca Targets Emerging Markets
Pharma and Healthcare Insight (registration)
In addition to the revenue upsides from Toprol-XL and H1N1 influenza vaccine sales, Crestor (rosuvastatin), Seroquel (quetiapine) and Symbicort (budesonide ...

continue reading

Your Ad Here

Our Services

Do not forget to check the lastest products and auctions related to Budesonide as well as our free videos and podcasts.

best Budesonide products current Budesonide auctions current Budesonide videos listen to Budesonide podcasts

This Day In History

Lionel Nathan Rothschild: became the first Jew to sit in the British Parliament — 11 years after he was elected; the House of Commons had to allow a special oath (1858)



The Asthma & Allergy Cure, Click Here!

Latest Posts

Asthma Free Forever